Breaking News Instant updates and real-time market news.

2023-02-08 05:11:25 BYPLF Bodycote $7.99 / + (+0.00%) 05:11 02/08/23 02/08 05:11 02/08/23 05:11	Bodycote downgraded to Sell from Hold at Panmure Gordon Panmure Gordon analyst Sanjay Jha downgraded Bodycote to Sell from Hold with a 543 GBp price target.

2023-02-08 05:11:25

BYPLF

Bodycote

$7.99 / + (+0.00%)

05:11

02/08/23

02/08

05:11

02/08/23

05:11

Bodycote downgraded to Sell from Hold at Panmure Gordon

Panmure Gordon analyst Sanjay Jha downgraded Bodycote to Sell from Hold with a 543 GBp price target.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Paysafe expands into Massachusetts » 05:06 03/30/23 03/30 05:06 03/30/23 05:06 PSFE Paysafe $16.87 / +0.48 (+2.93%) Paysafe announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/28/23 Greyhound Lines partners with Paysafe 01/18/23 Paysafe enters Ohio online sports-betting market 12/14/22 Paysafe falls -9.9% 12/14/22 Paysafe falls -8.5% PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/14/23 Susquehanna Paysafe guidance reiterated at analyst and Investor Day, says Susquehanna 03/10/23 Susquehanna Paysafe management has company growing again, says Susquehanna 08/31/22 Susquehanna Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see' 08/31/22 Susquehanna Paysafe downgraded to Neutral from Positive at Susquehanna PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/09/23 Paysafe sees FY23 revenue $1.58B-$1.6B, consensus $1.58B 03/09/23 Paysafe sees Q1 revenue $375M-$380M, consensus $376.88M 03/09/23 Paysafe reports Q4 adjusted EPS 54c, consensus 10c 11/10/22 Paysafe sees Q4 revenue $370M-$378M, consensus $370.81M PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/10/23 Sell these stocks now, proven algorithm says 03/09/23 Fly Intel: Pre-market Movers 02/03/23 Sell these stocks now, proven algorithm says 01/20/23 Sell these stocks now, proven algorithm says PSFE Paysafe $16.87 / +0.48 (+2.93%) 12/14/22 Notable open interest changes for December 14th
Recommendations	Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank » 05:06 03/30/23 03/30 05:06 03/30/23 05:06 WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) Deutsche Bank lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/14/23 Senate Democrats urge Walmart, Kroger, others to sell mifepristone 03/06/23 Walgreens Boots Alliance to dispense Mifepristone where 'legally permissible' 03/06/23 California 'done' with Walgreens over abortion pill stance 03/02/23 Walgreens with DoorDash, Uber announce free Same Day Rx Delivery for HIV WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/29/23 UBS Walgreens Boots Alliance price target lowered to $37 from $39 at UBS 03/29/23 Truist Walgreens Boots Alliance price target lowered to $40 from $42 at Truist 03/26/23 Barclays Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays 03/22/23 Evercore ISI Walgreens Boots Alliance price target lowered to $35 from $36 at Evercore ISI WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/28/23 Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51 03/28/23 Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10 03/27/23 Notable companies reporting before tomorrow's open 03/27/23 Notable companies reporting before tomorrow's open WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/08/23 Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report 03/03/23 Walgreens will not distribute abortion pills in 20 states, Reuters report 01/25/23 Walgreens weighing sale of $2B pharmacy automation business, Bloomberg says 01/19/23 Rite Aid plans to provide abortion pill in some stores, Bloomberg reports WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 Fly Intel: Pre-market Movers 03/06/23 What You Missed On Wall Street On Monday WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/28/23 Unusually active option classes on open March 28th 03/27/23 Unusually active option classes on open March 27th 03/13/23 Walgreen Boots call volume above normal and directionally bullish 01/05/23 Unusually active option classes on open January 5th
Upgrade	Equinor upgraded to Buy from Hold at Deutsche Bank » 05:04 03/30/23 03/30 05:04 03/30/23 05:04 EQNR Equinor $28.10 / -0.28 (-0.99%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options EQNR Equinor $28.10 / -0.28 (-0.99%) 03/20/23 Equinor to sell 28% working interest in PL037 for $220M 02/16/23 TechnipFMC awarded subsea project by Equinor for Verdande field 02/16/23 TechnipFMC awarded subsea contract for Equinor's Irpa development 02/16/23 Shell begins production at Vito in U.S. Gulf of Mexico EQNR Equinor $28.10 / -0.28 (-0.99%) 03/22/23 Societe Generale Equinor upgraded to Buy at Societe Generale following selloff 03/22/23 Societe Generale Equinor upgraded to Buy from Hold at Societe Generale 03/21/23 Morgan Stanley Equinor price target lowered to NOK 325 from NOK 360 at Morgan Stanley 02/24/23 JPMorgan Equinor price target raised to NOK 310 from NOK 290 at JPMorgan EQNR Equinor $28.10 / -0.28 (-0.99%) 10/17/22 Russia 'unilaterally terminated' Exxon's interests in oil project, Reuters says EQNR Equinor $28.10 / -0.28 (-0.99%) 01/30/23 Largest borrow rate increases among liquid names
Upgrade	ProQR Therapeutics upgraded to Outperform from Market Perform at JMP Securities » 05:02 03/30/23 03/30 05:02 03/30/23 05:02 PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 03/29/23 ProQR announces initial pipeline targets, highlights Axiomer platfotform 03/14/23 ProQR Therapeutics announces successful defense of Axiomer patent pending 03/07/23 ProQR Therapeutics to present on Axiomer RNA editing technology platform 12/22/22 Eli Lilly, ProQR expand genetic medicines licensing and collaboration agreement PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 03/10/23 Stifel Stifel says SVB fallout 'appears limited' across firm's biotech coverage 12/28/22 Cantor Fitzgerald Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James 12/22/22 JMP Securities ProQR Therapeutics shares remain 'fairly valued,' says JMP Securities PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 11/09/22 ProQR Therapeutics reports Q3 EPS (EUR 0.34) vs (EUR 0.22) last year PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 12/22/22 Fly Intel: Pre-market Movers
Upgrade	Proximus upgraded to Neutral from Underperform at Exane BNP Paribas » 04:58 03/30/23 03/30 04:58 03/30/23 04:58 BGAOY Proximus $1.80 / + (+0.00%) Exane BNP Paribas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BGAOY Proximus $1.80 / + (+0.00%) 03/21/23 UBS Proximus upgraded to Neutral from Sell at UBS 01/18/23 HSBC Proximus upgraded to Hold from Reduce at HSBC 01/12/23 Deutsche Bank Proximus price target lowered to EUR 11 from EUR 12.50 at Deutsche Bank 01/12/23 Citi Proximus upgraded to Buy from Neutral at Citi
Upgrade	Tele2 upgraded to Outperform from Neutral at Exane BNP Paribas » 04:57 03/30/23 03/30 04:57 03/30/23 04:57 TLTZY Tele2 $4.85 / +0.11 (+2.32%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLTZY Tele2 $4.85 / +0.11 (+2.32%) 03/21/23 JPMorgan Tele2 price target lowered to SEK 120 from SEK 142 at JPMorgan 02/02/23 Morgan Stanley Tele2 price target lowered to SEK 105 from SEK 120 at Morgan Stanley 02/01/23 Barclays Tele2 price target lowered to SEK 130 from SEK 135 at Barclays 02/01/23 Citi Tele2 price target lowered to SEK 94 from SEK 98 at Citi
Downgrade	Telefonica Deutschland downgraded to Underperform at Exane BNP Paribas » 04:57 03/30/23 03/30 04:57 03/30/23 04:57 TELDF Telefonica Deutschland $3.05 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TELDF Telefonica Deutschland $3.05 / + (+0.00%) 03/14/23 Credit Suisse Telefonica Deutschland downgraded to Neutral from Outperform at Credit Suisse 03/06/23 Citi Telefonica Deutschland downgraded to Neutral from Buy at Citi 02/23/23 DZ Bank Telefonica Deutschland downgraded to Hold from Buy at DZ Bank 11/04/22 Credit Suisse Telefonica Deutschland price target raised to EUR 3.10 at Credit Suisse
Downgrade	KPN downgraded to Neutral from Outperform at Exane BNP Paribas » 04:56 03/30/23 03/30 04:56 03/30/23 04:56 KKPNY KPN $3.58 / +0.03 (+0.85%) Exane BNP Paribas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KKPNY KPN $3.58 / +0.03 (+0.85%) 02/23/23 Berenberg KPN downgraded to Hold from Buy at Berenberg 02/13/23 JPMorgan KPN price target lowered to EUR 4.30 from EUR 4.40 at JPMorgan 02/08/23 Morgan Stanley KPN price target raised to EUR 3.70 from EUR 3.60 at Morgan Stanley 01/05/23 JPMorgan KPN price target raised to EUR 4.40 from EUR 4.20 at JPMorgan
Upgrade	Telefonica upgraded to Outperform from Underperform at Exane BNP Paribas » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 TEF Telefonica $4.21 / +0.105 (+2.56%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals TEF Telefonica $4.21 / +0.105 (+2.56%) 02/21/23 Amazon launches 'Integrated Private Wireless' with telco companies 10/25/22 Telefonica announces tax refund of over EUR 1.3B TEF Telefonica $4.21 / +0.105 (+2.56%) 03/21/23 JPMorgan Telefonica price target raised to EUR 2.70 from EUR 2.50 at JPMorgan 02/20/23 Deutsche Bank Telefonica downgraded to Hold from Buy at Deutsche Bank 02/14/23 Bryan Garnier Telefonica initiated with a Neutral at Bryan Garnier 01/05/23 JPMorgan Telefonica price target lowered to EUR 2.50 from EUR 2.70 at JPMorgan TEF Telefonica $4.21 / +0.105 (+2.56%) 10/25/22 Liberty, Telefonica exploring sale of Cornerstone stake, Bloomberg reports
Conference/Events	Jefferies software analyst to hold an analyst/industry conference call » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 HUBS HubSpot $411.68 / +7.72 (+1.91%) Software Analyst Samana,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/17/23 HubSpot rises 13.7% 02/16/23 HubSpot jumps 12% to $406 after Q4 earnings beat, above-consensus outlook 01/31/23 HubSpot announces restructuring plan, 7% workforce reduction 12/22/22 HubSpot Executive Chair sells $2.4M in common stock HUBS HubSpot $411.68 / +7.72 (+1.91%) 03/12/23 Barclays Barclays reveals software names that could be impacted by SVB 02/24/23 Jefferies HubSpot price target raised to $450 from $400 at Jefferies 02/19/23 Barclays HubSpot price target raised to $400 from $325 at Barclays 02/17/23 RBC Capital HubSpot price target raised to $500 from $380 at RBC Capital HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/16/23 HubSpot sees FY23 EPS $4.24-$4.32, consensus $2.86 02/16/23 HubSpot sees Q1 EPS 82c-84c, consensus 59c 02/16/23 HubSpot reports Q4 EPS $1.17, consensus 82c 02/16/23 Notable companies reporting after market close HUBS HubSpot $411.68 / +7.72 (+1.91%) 12/03/22 Tapestry, Saia among small-cap stocks set for big gains, Barron's says HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning 02/17/23 Fly Intel: Pre-market Movers 02/16/23 Fly Intel: After-Hours Movers 11:00 Today Software HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/16/23 HubSpot options imply 5.7% move in share price post-earnings

Conference/Events	Tyler Technologies management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 TYL Tyler Technologies $341.05 / +9.755 (+2.94%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 03/15/23 Tyler Technologies chairman sells $2.44M in common stock 03/13/23 Tyler Technologies CFO Miller sells 3,639 common shares 03/07/23 Tyler Technologies renews digital government, payment solutions in Colorado 03/01/23 Tyler Technologies acquires Safeground Analytics, terms undisclosed TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 03/17/23 Piper Sandler Piper Sandler sees buying opportunity in shares of Tyler Technologies 02/21/23 Credit Suisse Tyler Technologies price target lowered to $370 from $375 at Credit Suisse 02/17/23 JMP Securities Tyler Technologies price target lowered to $415 from $465 at JMP Securities 02/17/23 Piper Sandler Tyler Technologies price target lowered to $450 from $468 at Piper Sandler TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 02/15/23 Tyler Technologies sees FY23 adjusted EPS $7.50-$7.65, consensus $7.75 02/15/23 Tyler Technologies reports Q4 adjusted EPS $1.66, consensus $1.75 10/26/22 Tyler raises FY22 EPS view to $7.51-$7.65 from $7.36-$7.52, consensus $7.46 10/26/22 Tyler reports Q3 adjusted EPS $2.06, consensus $1.86 TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 02/15/23 Fly Intel: After-Hours Movers 11/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Tyler Technologies - TYL 00:00 Today Tyler Technologies TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 12/13/22 Early notable gainers among liquid option names on December 13th
Conference/Events	Compass Pathways management to meet virtually with Cantor Fitzgerald » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 CMPS Compass Pathways $10.56 / +0.31 (+3.02%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 02/28/23 Compass Pathways sees 2023 net cash use $85M-$110M 01/26/23 Cathie Wood's ARK Investment bought 120.3K shares of Compass Pathways today 01/19/23 Cathie Wood's ARK Investment bought 158.2K shares of Compass Pathways today 01/18/23 Cathie Wood's ARK Investment bought 156.6K shares of Compass Pathways today CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 01/09/23 Loop Capital Atai Life Sciences price target lowered to $10 from $18 at Loop Capital 12/15/22 EF Hutton Compass Pathways initiated with a Buy at EF Hutton 12/09/22 Oppenheimer Compass Pathways price target lowered to $33 from $55 at Oppenheimer 11/01/22 Loop Capital Compass Pathways initiated with a Buy at Loop Capital CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 02/28/23 Compass Pathways reports Q4 EPS (73c), consensus (59c) 11/03/22 Compass Pathways reports Q3 EPS (43c), consensus (65c) CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 01/03/23 Oregon becomes first U.S. state to legalize 'magic' mushrooms, NYT says CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 03/23/23 Here's What You Missed in Cannabis, Psychedelics This Week 03/16/23 Rising High: Exclusive talk with house of brands Carma HoldCo 03/09/23 Rising High: Exclusive talk with cannabinoid market research firm BDSA 03/02/23 Rising High: Exclusive talk with vertically-integrated MSO Greenlight 00:00 Today Compass Pathways
Conference/Events	Collegium Pharmaceutical management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 02/22/23 Collegium Pharmaceutical publishes inaugural ESG report 01/04/23 Collegium Pharmaceutical board authorizes $100M share repurchase program 12/22/22 Collegium Pharmaceutical says appeals court affirms validity of Belbuca patents COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 01/05/23 Needham Collegium Pharmaceutical price target raised to $35 from $34 at Needham 08/08/22 H.C. Wainwright Collegium Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 02/23/23 Collegium Pharmaceutical reports Q4 EPS $1.09, consensus (14c) 02/06/23 Collegium reports preliminary Q4 revenue $125.7M-$128.2M, consensus $123.17M 01/04/23 Collegium Pharmaceutical sees 2023 product revenue $565M-$580M 11/03/22 Collegium Pharmaceutical reports Q3 EPS 1c, consensus (13c) COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 01/04/23 What You Missed On Wall Street This Morning 00:00 Today Collegium Pharmaceutical
Conference/Events	Guidewire management to meet with JPMorgan » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 GWRE Guidewire $77.58 / +1.27 (+1.66%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GWRE Guidewire $77.58 / +1.27 (+1.66%) 01/12/23 Guidewire, Assurant partner to streamline insurance processes 10/24/22 Guidewire announces strategic payments partnership with One Inc 10/21/22 Guidewire appoints David Laker as chief sales officer GWRE Guidewire $77.58 / +1.27 (+1.66%) 03/07/23 Stifel Guidewire price target raised to $72 from $60 at Stifel 03/07/23 Baird Guidewire price target raised to $80 from $75 at Baird 03/07/23 Wells Fargo Guidewire price target raised to $60 from $55 at Wells Fargo 03/07/23 Citi Guidewire price target raised to $81 from $67 at Citi GWRE Guidewire $77.58 / +1.27 (+1.66%) 03/06/23 Guidewire raises FY23 revenue view to $894M-$904M from $886M-$896M 03/06/23 Guidewire sees Q3 revenue $211M-$216M, consensus $213.7M 03/06/23 Guidewire reports Q2 adjusted EPS (21c), consensus (3c) 12/06/22 Guidewire raises FY23 revenue view to $886M-$896M from $885M-$895M GWRE Guidewire $77.58 / +1.27 (+1.66%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/06/22 Fly Intel: After-Hours Movers 12/01/22 Fly Intel: Pre-market Movers 00:00 Today Guidewire 04/05/23 Guidewire
Conference/Events	Shift Technologies to meet virtually with Oppenheimer » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 SFT Shift Technologies $1.20 / -0.46 (-27.71%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SFT Shift Technologies $1.20 / -0.46 (-27.71%) 03/07/23 Shift Technologies announces 1-for-10 reverse stock split 02/02/23 Shift Technologies to exit East Coast stores acquired via CarLotz merger 12/09/22 Shift Technologies closes merger with CarLotz SFT Shift Technologies $1.20 / -0.46 (-27.71%) 02/16/23 Piper Sandler Piper downgrades Shift Technologies on going out of business concerns 02/16/23 Piper Sandler Shift Technologies downgraded to Neutral from Overweight at Piper Sandler 11/10/22 Oppenheimer Shift Technologies downgraded on near-term challenges at Oppenheimer 11/10/22 Oppenheimer Shift Technologies downgraded to Perform from Outperform at Oppenheimer SFT Shift Technologies $1.20 / -0.46 (-27.71%) 03/28/23 Shift Technologies reports Q4 EPS $1.25, consensus ($4.68) SFT Shift Technologies $1.20 / -0.46 (-27.71%) 11/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today Shift Technologies
Conference/Events	Cal-Maine Foods to participate in a conference call with Stephens » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) Food/Agribusiness Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/28/23 Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration 03/27/23 Cal-Maine Foods names Todd Walters COO 02/06/23 Reed asked FTC to crack down on possible egg price gouging 01/19/23 Cal-Maine Foods in partnership with Entegrity to install solar array CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/24/23 Lake Street Vital Farms initiated with a Buy at Lake Street 12/29/22 BofA Cal-Maine earnings miss to weigh on shares, says BofA 09/28/22 BofA Cal-Maine Foods price target lowered to $50 from $55 at BofA 03/30/22 Consumer Edge Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/28/23 Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47 12/28/22 Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24 CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/29/23 What You Missed On Wall Street On Wednesday 03/29/23 What You Missed On Wall Street This Morning 03/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/29/22 Fly Intel: Pre-market Movers 10:00 Today Cal-Maine Foods - CALM CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/28/23 Cal Maine Foods options imply 5.8% move in share price post-earnings 12/28/22 Cal Maine Foods options imply 4.0% move in share price post-earnings
Conference/Events	CymaBay management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 CBAY CymaBay $8.77 / -0.055 (-0.62%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CBAY CymaBay $8.77 / -0.055 (-0.62%) 01/30/23 CymaBay announces closing of public offering of common stock 01/24/23 CymaBay up 11% at $7.32 after pricing stock offering above prior close 01/08/23 CymaBay announces collaboration with Kaken to develop, commercialize Seladelpar 11/04/22 CymaBay presents additional analyses from studies of seladelpar CBAY CymaBay $8.77 / -0.055 (-0.62%) 03/17/23 H.C. Wainwright CymaBay price target raised to $12 from $10 at H.C. Wainwright 03/09/23 BTIG CymaBay initiated with a Buy at BTIG 01/31/23 Cantor Fitzgerald CymaBay price target raised to $13 from $10 at Cantor Fitzgerald 01/29/23 Piper Sandler CymaBay price target raised to $19 from $12 at Piper Sandler CBAY CymaBay $8.77 / -0.055 (-0.62%) 03/16/23 CymaBay reports Q4 EPS (30c), consensus (30c) 11/14/22 CymaBay reports Q3 EPS (28c), consensus (30c) 24 Jan CBAY CymaBay $8.77 / -0.055 (-0.62%) 03/20/23 Biotech Alert: Searches spiking for these stocks today 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 12/05/22 Biotech Alert: Searches spiking for these stocks today 00:00 Today CymaBay
Conference/Events	Franklin BSP Realty Trust participates in a conference call with B. Riley » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 FBRT Franklin BSP Realty Trust $11.47 / +0.165 (+1.46%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events FBRT Franklin BSP Realty Trust $11.47 / +0.165 (+1.46%) 09/28/22 B. Riley Franklin BSP Realty Trust initiated with Buy, $16 target at B. Riley 09/28/22 B. Riley Franklin BSP Realty Trust initiated with a Buy at B. Riley 08/18/22 JMP Securities Franklin BSP downgraded to Market Perform from Outperform at JMP Securities 04/08/22 JonesTrading Franklin BSP Realty Trust initiated with a Buy at JonesTrading FBRT Franklin BSP Realty Trust $11.47 / +0.165 (+1.46%) 02/22/23 Franklin BSP Realty Trust reports Q4 distributable EPS 37c, consensus 36c 00:00 Today Franklin BSP Realty Trust - FBRT
Conference/Events	Stride management to meet with Barrington » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 LRN Stride $38.77 / -0.75 (-1.90%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LRN Stride $38.77 / -0.75 (-1.90%) 01/25/23 Stride rises 27.8% 01/25/23 Stride rises 29.0% 01/25/23 Stride rises 30.4% 01/24/23 Stride jumps 13% after Q2 earnings beat, FY23 guidance raise LRN Stride $38.77 / -0.75 (-1.90%) 03/10/23 Morgan Stanley Stride downgraded to Equal Weight from Overweight at Morgan Stanley 01/26/23 BMO Capital Stride price target raised to $48 from $47 at BMO Capital 10/26/22 Barrington Stride should be bought on post-earnings weakness, says Barrington 08/25/22 Morgan Stanley Stride upgraded to Overweight from Equal Weight at Morgan Stanley LRN Stride $38.77 / -0.75 (-1.90%) 01/24/23 Stride raises FY23 revenue view to $1.775B-$1.815B from $1.71B-$1.79B 01/24/23 Stride sees Q3 revenue $445M-$465M 01/24/23 Stride reports Q2 EPS $1.19, consensus $1.04 10/25/22 Stride guides initial FY23 revenue view of $.171B-$1.79B, consensus $1.78B LRN Stride $38.77 / -0.75 (-1.90%) 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers 01/24/23 Fly Intel: After-Hours Movers 00:00 Today Stride
Conference/Events	Vizio management to meet with Stephens » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 VZIO Vizio $8.80 / -0.02 (-0.23%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VZIO Vizio $8.80 / -0.02 (-0.23%) 02/27/23 Vizio appoints Mike Mohan to board of directors 10/20/22 Vizio leverages SpringServe Tiles to enhance content discovery 10/19/22 U.S. ITC institutes investigation of Vizio smart TVs at request of Maxell 10/06/22 Vizio reports 100% increase in direct advertising commitments year-over-year VZIO Vizio $8.80 / -0.02 (-0.23%) 03/01/23 Stephens Vizio price target lowered to $17 from $21 at Stephens 01/27/23 JPMorgan Vizio price target lowered to $13 from $15 at JPMorgan 01/04/23 Guggenheim Roku announces launch of first TV lines, says Guggenheim 01/03/23 Stephens Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023 VZIO Vizio $8.80 / -0.02 (-0.23%) 02/28/23 Vizio sees FY23 adjusted EBITDA $0M-$5M 02/28/23 Vizio reports Q4 EPS 3c, consensus 2c 11/09/22 Vizio sees Q4 adjusted EBITDA $15M-$19M 11/09/22 Vizio reports Q3 EPS 1c, consensus 1c VZIO Vizio $8.80 / -0.02 (-0.23%) 10/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/18/23 Virtual Spring Investment Conference 00:00 Today Vizio

Conference/Events	Sherwin-Williams management to meet with Mizuho » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 01/26/23 Sherwin-Williams: 2023 base case remains to 'prepare for the worst' 01/26/23 Sherwin-Williams falls -10.7% 11/08/22 Sherwin-Williams to acquire Oskar Nolte GmbH, Klumpp Coatings GmbH 10/25/22 Sherwin-Williams jumps 5% to $223.00 after Q3 results beat estimates SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 02/08/23 KeyBanc Sherwin-Williams downgraded to Sector Weight from Overweight at KeyBanc 01/31/23 RBC Capital Sherwin-Williams price target lowered to $267 from $285 at RBC Capital 01/30/23 Barclays Sherwin-Williams price target lowered to $220 from $245 at Barclays 01/27/23 BMO Capital Sherwin-Williams price target lowered to $231 from $283 at BMO Capital SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 01/26/23 Sherwin-Williams sees Q1 revenue growth flat to up in mid-single digits 01/26/23 Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $10.14 01/26/23 Sherwin-Williams reports Q4 adjusted EPS $1.89, consensus $1.86 01/25/23 Notable companies reporting before tomorrow's open SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 02/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/26/23 What You Missed On Wall Street On Thursday 01/26/23 What You Missed On Wall Street This Morning 01/26/23 Fly Intel: Pre-market Movers 00:00 Today Sherwin-Williams 04/19/23 The Sherwin-Williams Company 06/05/23 Sherwin-Williams
Conference/Events	RXO Inc. management to meet with Oppenheimer » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 RXO RXO Inc. $19.39 / +0.075 (+0.39%) Meeting to be held on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/07/23 RXO Inc. confident in achieving 5-year financial targets 01/04/23 RXO to replace The Joint in the S&P SmallCap 600 at open on January 5 12/29/22 RXO Inc. rises 5.4% 12/28/22 RXO Inc up 4% at $16.90 after entering S&P SmallCap 600 index RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/27/23 Cowen RXO Inc. initiated with a Market Perform at Cowen 01/11/23 Stifel RXO Inc. downgraded to Hold from Buy at Stifel 01/09/23 JPMorgan RXO Inc. initiated with a Neutral at JPMorgan 12/30/22 BofA XPO Logistics downgraded to Neutral at BofA amid demand deceleration RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/07/23 RXO Inc. reports Q4 adjusted EPS 28c, consensus 30c RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/28/22 Fly Intel: After-Hours Movers 12/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today RXO Inc. RXO RXO Inc. $19.39 / +0.075 (+0.39%) 11/04/22 One new option listing and one option delisting on November 4th
Conference/Events	FDA PDUFA Date for Regeneron Evkeeza (evinacumab) March 30, 2023 04:55 03/30/23 03/30 04:55 03/30/23 04:55 REGN Regeneron $819.01 / -6.615 (-0.80%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options REGN Regeneron $819.01 / -6.615 (-0.80%) 03/29/23 Regeneron announces EC approved Libtayo in combination with chemotherapy 03/28/23 Immuneering appoints Harold Brakewood as CBO 03/28/23 Regeneron Pharmaceuticals, Sonoma Biotherapeutics announce collaboration 03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints REGN Regeneron $819.01 / -6.615 (-0.80%) 03/29/23 Capital One Kodiak Q4 update had 'a few nice surprises,' says Capital One 03/29/23 BofA Regeneron price target raised to $650 from $605 at BofA 03/28/23 Erste Group Regeneron resumed with a Buy at Erste Group 03/27/23 SVB Securities SVB Securities upgrades Regeneron to Outperform, sees positive drivers ahead REGN Regeneron $819.01 / -6.615 (-0.80%) 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea REGN Regeneron $819.01 / -6.615 (-0.80%) 11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says REGN Regeneron $819.01 / -6.615 (-0.80%) 03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning 00:00 Today PDUFA Date for Evkeeza (evinacumab) 08/20/23 PDUFA Date for Pozelimab REGN Regeneron $819.01 / -6.615 (-0.80%) 03/23/23 Early notable gainers among liquid option names on March 23rd
Conference/Events	Jefferies UK industrials analysts to hold an analyst/industry conference call » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 UK Industrials Analysts,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Sonendo management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 SONX Sonendo $1.71 / -0.115 (-6.32%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SONX Sonendo $1.71 / -0.115 (-6.32%) 01/04/23 Sonendo unit files patent infringement lawsuit against Biolase 11/01/22 Sonendo announces Health Canada approval to sell GentleWave G4 System SONX Sonendo $1.71 / -0.115 (-6.32%) 10/04/22 Stifel Sonendo price target lowered to $3 from $4 at Stifel 10/03/22 Piper Sandler Sonendo price target lowered to $2.50 from $5.00 at Piper Sandler 08/10/22 Piper Sandler Sonendo price target lowered to $5 from $7 at Piper Sandler 06/17/22 Stifel Sonendo price target lowered to $6 from $10 at Stifel SONX Sonendo $1.71 / -0.115 (-6.32%) 03/08/23 Sonendo sees FY23 revenue $48M-$51M, consensus $51.29M 03/08/23 Sonendo reports Q4 EPS (12c), consensus (21c) 11/09/22 Sonendo backs FY22 revenue view $40.5M-$42.5M, consensus $41.43M 11/09/22 Sonendo reports Q3 EPS (47c), consensus (42c) 00:00 Today Sonendo

Events

Earnings calls, analyst events, roadshows and more

CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
QBTS
Today at 08:00

D-Wave Quantum - QBTS Conference Calls
GTEC
Today at 08:00

Greenland Technologies - GTEC Conference Calls
ANGO
Today at 08:00

AngioDynamics - ANGO Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
NEOG
Today at 08:00

Neogen - NEOG Conference Calls
TRVN
Today at 08:00

Trevena - TRVN Conference Calls
CZOO
Today at 08:00

Cazoo - CZOO Conference Calls
BCLI
Today at 08:00

BrainStorm - BCLI Conference Calls
RMTI
Today at 08:00

Rockwell Medical - RMTI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	HLP X HLP Hongli Group IPO Managers: EF Hutton Priced at: $4.00 2.06M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AVDL X AVDL Avadel Pharmaceuticals Spot Secondary Managers: Jefferies, LifeSci Capital, H.C. Wainwright, Oppenheimer, Needham Priced at: $8.50 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CHSN X CHSN Chanson International IPO Managers: EF Hutton $4.00-6.00 3.75M Shares MGIH X MGIH Millennium Group IPO Managers: Revere & R.F. Lafferty $4.00 1.25M Shares TCJH X TCJH Top KingWin IPO Managers: Univest Securities $4.00-5.00 3M Shares BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VKTX X VKTX Viking Therapeutics Spot Secondary Managers: William Blair, Raymond James $14.50-15.00
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Bodycote downgraded to Sell from Hold at Panmure Gordon

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access